Iovance Biotherapeutics Inc (IOVA)
11.44
-0.02
(-0.17%)
USD |
NASDAQ |
Nov 05, 11:29
Iovance Biotherapeutics Gross Profit Margin (Quarterly): -0.84% for June 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -0.84% |
| March 31, 2024 | -915.5% |
| December 31, 2023 | -805.6% |
| Date | Value |
|---|---|
| September 30, 2023 | -825.4% |
| June 30, 2023 | -761.3% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-915.5%
Minimum
Mar 2024
-0.84%
Maximum
Jun 2024
-661.7%
Average
-805.6%
Median
Dec 2023
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 76.19% |
| Xtant Medical Holdings Inc | 62.06% |
| Myomo Inc | 70.81% |
| Catheter Precision Inc | 82.80% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -66.99% |
| Return on Assets | -52.11% |
| Return on Invested Capital | -66.89% |
| Profit Margin (Quarterly) | -312.2% |
| Operating Margin (Quarterly) | -327.6% |
| Return on Net Operating Assets | -96.36% |